USPTO 2015–2025 USPTO PatentsView US Corporation

AMO Development, Llc

USPTO PatentsView assignee record - 283 granted patents across 24 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

283

Total patents granted

CPC technology areas

14.0

Avg claims per patent

+256%

5-year filing velocity

The verdict

AMO holds 283 US patents across 24 technology areas, rank #1,467 of 50,000 tracked assignees.

#1,467
of 50,000 US assignees by volume: Top 9%
by Innovation Score (53.0/100): 14.0
avg claims per patent: +256%
filing velocity, last 5 yrs

Portfolio overview

AMO Development, Llc has been granted 283 US utility patents between 2015 and 2025, placing AMO Development, Llc at rank #1,467 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.0 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, AMO Development, Llc is one of the more focused assignees in the PatentsView dataset. By volume, AMO sits between Sivantos Pte. Ltd. (284 patents, rank #1,463) and Atieva, Inc. (282 patents, rank #1,471) - the closest US assignees by grant volume. The composite Innovation Score of 53.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 221 grants, compared with 62 in the 2015–2019 window, a +256% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. AMO Development, Llc's 14.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark AMO Development, Llc against peers pursuing similar technology classes.

Sivantos Pte

284
Toshiba Infrastru…

284
Trend Micro Incor…

284
Xiamen ECO Lighti…

284
Ab Initio Technol…

283
Firmenich

283
Nanjing Chervon I…

283
AMO Development ◀

283
Atieva

282

What this shows AMO holds 283 patents at rank #1,467, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AMO

By rank, the assignees closest to #1,467 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in AMO's primary technology class.

AMO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

AMO Development, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	3.5%
2016	16	5.7%
2017	15	5.3%
2018	7	2.5%
2019	14	4.9%
2020	52	18.4%
2021	35	12.4%
2022	31	11.0%
2023	40	14.1%
2024	46	16.3%
2025	17	6.0%

Which technologies does AMO Development, Llc patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 255

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 154

G02C - SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES 14

G01B - MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS 14

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 14

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 12

B23K - SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM 12

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 7

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 5

B29K - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR ; MOULDS, ; REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS 5

B29D - PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE 5

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 5

G01J - MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY 5

G06F - ELECTRIC DIGITAL DATA PROCESSING 5

Top 15 of 24 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#1,467

Across all tracked assignees

Innovation Score

53.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does AMO Development, Llc hold?

AMO Development, Llc holds 283 US granted patents filed between 2015 and 2025, spanning 24 technology areas.

What is AMO Development, Llc's Innovation Score?

AMO Development, Llc has an Innovation Score of 53.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does AMO Development, Llc focus on?

AMO Development, Llc's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 255 patents. The company has filed patents in 24 CPC subclasses total.

Is AMO Development, Llc's patent filing rate increasing or decreasing?

AMO Development, Llc's recent filing velocity is +256% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for AMO Development, Llc's patents?

AMO Development, Llc's patents average 14.0 claims each. This falls within the standard range, providing solid legal coverage.

How is the AMO Development, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

AMO's 283 grants land it in the top 9% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - AMO ranks #1,467 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.